Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Inv Regulatory News (IIG)

Share Price Information for Intuitive Inv (IIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.00
Bid: 125.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 10.00 (8.00%)
Open: 130.00
High: 130.00
Low: 130.00
Prev. Close: 130.00
IIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reorganisation and Deferred Consideration

24 May 2023 07:00

RNS Number : 4034A
Intuitive Investments Group plc
24 May 2023
 

24 May 2023

 

Intuitive Investments Group plc

 

Reorganisation and Deferred Consideration

 

Reorganisation of investment and reduction in deferred consideration

 

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, announces the proposed reorganisation of Touchless Innovation Limited ("Touchless Innovation") and Touch-Less Hygiene UK Limited ("Touch-Less Hygiene") (together the "Touchless Group") and the reduction in the deferred consideration payable to the vendors of the business and assets of Sanoserv International Franchising Limited.

 

Reorganisation of Touchless Innovation Limited and Touch-Less Hygiene UK Limited

 

The Board of Touchless Innovation, with the agreement of the Board of IIG, has decided to move Touch-Less Hygiene from being a wholly owned subsidiary of Touchless Innovation to beinga wholly owned subsidiary of IIG. Touchless Innovation and Touch-Less Hygiene have different business models. Touchless Innovation is an international franchising business, with master franchisees in 11 countries. Touch-Less Hygiene is a UK market-leading provider of specialist disinfection and decontamination services, with 25 regional sites in the UK and customers that include blue-chip life sciences companies, essential infrastructure firms and the NHS. Given the distinct business models, the board of Touchless Innovation believes that separating and having distinct management teams, will improve both the opportunity for growth and the potential to attract third party funding.

 

Reduction in Deferred Consideration

 

As announced on 25 February 2022, Touchless Innovationacquired the business and assets of Sanoserv International Franchising Limited. The consideration payable by Touchless Innovation to the vendors included £900,000 of deferred consideration payable six months from completion (on 25 August 2022). In substitution for the £900,000 the Boards of IIG and Touchless Innovation have agreed to issue the vendors 2,000,000 new ordinary shares of 1 penny each in IIG ("Consideration Shares"), as well as allowing the vendors the master franchise for Malta for nine years. The minimum royalty amount under the master franchise agreement is $5,400 per annum. In addition, the vendors no longer have the right to appoint a director to the Board of Touchless Innovation, the current cost of which is £25,000 per annum.

 

Admission to trading

 

Application has been made to the London Stock Exchange plc for the admission of the Consideration Shares to trading on AIM, which is expected to take effect at 8.00 a.m. on or around 30 May 2023 ("Admission"). The Consideration Shares will rank equally with the existing ordinary shares of 1 penny each in the share capital of the Company ("Ordinary Shares").

 

Following Admission, the Company's issued share capital will consist of 74,064,551 Ordinary Shares. Since the Company currently holds no shares in treasury, the total number of voting rights in the Company will be 74,064,551. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

For further information, please contact:

Intuitive Investments Group plc

+44 (0) 20 3657 0050

Julian Baines, Chairman

Robert Naylor, CEO

Via Turner Pope Investments (TPI) Ltd

 

SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0) 20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

 

Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope

 

 About Intuitive Investments Group plc

Intuitive Investments Group plc is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUORNROAUVUAR
Date   Source Headline
8th Apr 20247:00 amRNSIssue and Allotment of Ordinary Shares
22nd Mar 20249:00 amRNSIIG celebrates Sir Nigel Rudd’s award win
21st Mar 20247:00 amRNSIssue and Allotment of Ordinary Shares
7th Mar 20247:00 amRNSHui10 contract win
29th Feb 202410:36 amRNSResult of AGM
28th Feb 20247:00 amRNSIssue of shares
27th Feb 20247:00 amRNSHui10 approved to expand with China Sports Lottery
16th Feb 20247:00 amRNSAppointment of Corporate Broker
6th Feb 202410:45 amRNSPosting of Annual Report and AGM Notice
1st Feb 20242:23 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSFinancial Results
4th Jan 20242:54 pmRNSIssue of shares
29th Dec 20237:00 amRNSTotal Voting Rights
12th Dec 20233:48 pmRNSIssue of shares
28th Nov 20237:00 amRNSUpdate to the Board of Directors
3rd Nov 20231:36 pmRNSDirector Dealing
1st Nov 202310:41 amRNSHolding(s) in Company
27th Oct 20231:33 pmRNSDirector Dealing
27th Oct 20237:00 amRNSInvestment in Hui10 Inc
31st Aug 20238:25 amRNSTotal Voting Rights
10th Aug 202311:08 amRNSHolding(s) in Company
8th Aug 20238:00 amRNSReadmission - Intuitive Investments Group plc
28th Jul 20233:35 pmRNSGM, Tender Offer & Placing & Directorate Change
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
11th Jul 202310:47 amRNSNotice of General Meeting - Correction
11th Jul 20237:00 amRNSNotice of General Meeting to approve Proposals
11th Jul 20237:00 amRNSIIG appoints Sir Nigel Rudd as its next Chairman
5th Jul 20233:46 pmRNSFORM 8.3 - Yourgene Health Plc
29th Jun 20237:00 amRNSInterim report for the six months to 31 March 2023
31st May 20237:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSReorganisation and Deferred Consideration
26th Apr 20234:57 pmRNSHolding(s) in Company
17th Jan 202311:19 amRNSResult of AGM and Directorate Change
11th Jan 202310:00 amRNSInvestment in Yourgene Health plc
21st Dec 20227:00 amRNSFinal Results
7th Nov 20222:05 pmRNSSecond Price Monitoring Extn
7th Nov 20222:00 pmRNSPrice Monitoring Extension
5th Aug 20227:00 amRNSInvestment in PneumoWave Limited
26th May 20227:00 amRNSUpdate on Sanondaf
25th May 20227:00 amRNSHalf-year Report
20th Apr 202211:13 amRNSDispensation from Rule 9 of the Code
4th Apr 202211:13 amRNSTotal Voting Rights
8th Mar 20223:39 pmRNSHolding(s) in Company
2nd Mar 20227:00 amRNSSubscription
25th Feb 202212:11 pmRNSInvestment & Appointment of Non-Executive Chair
14th Feb 202212:59 pmRNSChange of Registered Office
14th Feb 20227:00 amRNSInvestment in Ocutec Limited
24th Jan 20228:45 amRNSDirector Dealing
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.